Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency

• Status: Completed
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This prospective, randomized, controlled study was approved by the Institutional Review Board of Hallym University Kangnam Sacred Heart Hospital (IRB no. 2018-04-017). All study participants consented the study and agreed the written informed consent. All participants who are applicable to the inclusion criteria were randomly assigned to two groups: the control group and the study group. Both groups were treated with phototherapy including 308-nm excimer laser or narrowband ultraviolet B (NB-UVB). Study group had vitamin D supplementation through the injection additionally.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hallym University Kangnam Sacred Heart Hospital
• Treatments: Cholecalciferol; Vitamin D

Criteria

Inclusion Criteria:

1. patients diagnosed with non-segmental vitiligo based on clinical diagnosis.

2. patients who were ≥ 18 years old.

3. patients with lower serum vitamin D level (<20ng/mL).

Exclusion Criteria:

1. patients taking medicines such as thiazide, diuretics, lithium which can influence the serum vitamin D level.

2. pregnant or lactating women.

3. patients with diseases which can affect kidney such as chronic kidney disease, hyperparathyroidism, or hypoparathyroidism.

4. patients with uncontrolled chronic diseases like diabetes mellitus, hyperlipidemia, hypertension

5. patients whose spot urine calcium level was over 30mg/dL.